Metro Minnesota Community Oncology Research Consortium (MMCORC) /ID# 274780

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Ovarian cancer

Running trials

• Recruiting

  A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  NCT06890338· Phase 2· AbbVie· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ovarian cancer1 recruiting